Kushner, Rzewnicki: "The acute phase response: general aspects." in: Baillière's clinical rheumatology, Vol. 8, Issue 3, pp. 513-30, 1994 (PubMed).
Macy, Hayes, Tracy: "Variability in the measurement of C-reactive protein in healthy subjects: implications for reference intervals and epidemiological applications." in: Clinical chemistry, Vol. 43, Issue 1, pp. 52-8, 1997 (PubMed).
Ridker, Cushman, Stampfer et al.: "Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men." in: The New England journal of medicine, Vol. 336, Issue 14, pp. 973-9, 1997 (PubMed).
Ridker, Glynn, Hennekens: "C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction." in: Circulation, Vol. 97, Issue 20, pp. 2007-11, 1998 (PubMed).
Ridker, Rifai, Pfeffer et al.: "Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events (CARE) Investigators." in: Circulation, Vol. 98, Issue 9, pp. 839-44, 1998 (PubMed).
Yudkin, Stehouwer, Emeis et al.: "C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue?" in: Arteriosclerosis, thrombosis, and vascular biology, Vol. 19, Issue 4, pp. 972-8, 1999 (PubMed).
Kimberly, Vesper, Caudill et al.: "Standardization of immunoassays for measurement of high-sensitivity C-reactive protein. Phase I: evaluation of secondary reference materials." in: Clinical chemistry, Vol. 49, Issue 4, pp. 611-6, 2003 (PubMed).